Rein Therapeutics
RNTX
#10291
Rank
NZ$94.81 M
Marketcap
NZ$1.10
Share price
3.68%
Change (1 day)
-59.72%
Change (1 year)

Earnings for Rein Therapeutics (RNTX)

Earnings in 2026 (TTM): -NZ$36.11 Million

According to Rein Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$39.41 Million, an increase over its 2024 earnings that were of -NZ$50.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rein Therapeutics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$36.11 Million-8.38%
2025 -NZ$39.41 Million-21.99%
2024 -NZ$50.52 Million83.16%
2023 -NZ$27.58 Million-44.49%
2022 -NZ$49.68 Million3.92%
2021 -NZ$47.81 Million29.81%
2020 -NZ$36.83 Million-31.58%
2019 -NZ$53.83 Million-6.1%
2018 -NZ$57.33 Million38.66%
2017 -NZ$41.35 Million26.63%
2016 -NZ$32.65 Million